Stock Price Forecast

March 18, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading GlycoMimetics Inc chart...

About the Company

at glycomimetics, we are committed to helping to make a difference in the lives of people living with sickle cell, cancer, and other serious diseases. our mission is to continue to advance our research and clinical candidates, providing hope for patients as we strive for tomorrow’s breakthrough treatments. glycomimetics is a clinical-stage biotechnology company. we use novel and proprietary glycobiology technology to develop treatments for diseases, particularly where there is high unmet need. since the company’s inception in 2003, we have developed a robust, diversified product pipeline. we are a public company traded on the nasdaq under the symbol glyc.

CEO

Rachel King

Exchange

NASDAQ

Website

http://glycomimetics.com/

$0M

Total Revenue

54

Employees

$180M

Market Capitalization

-4.63

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $GLYC News

GlycoMimetics Inc hosts conference call for investors

2d ago, source:

The company, GlycoMimetics Inc, is set to host investors and clients on a conference call on 3/27/2024 8:59:30 AM. The call comes after the ...

Positive Signs As Multiple Insiders Buy GlycoMimetics Stock

14d ago, source:

Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying, like in ...

GlycoMimetics Inc GLYC

3d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

GlycoMimetics, Inc. (GKO.F)

24d ago, source: Yahoo Finance

ROCKVILLE, Md., February 12, 2024--GlycoMimetics, Inc. (the "Company") (NASDAQ:GLYC) today announced that the Compensation Committee of the Company’s Board of Directors approved the grant on ...

GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

1mon ago, source: Stockhouse

GlycoMimetics, Inc. (the “Company”) (NASDAQ:GLYC) today announced that the Compensation Committee of the Company’s Board of Directors approved the grant on ...

GlycoMimetics to Participate in Upcoming Cowen 44th Annual Health Care Conference

22d ago, source: Yahoo Finance

ROCKVILLE, Md., February 26, 2024--(BUSINESS WIRE)--GlycoMimetics, Inc. (Nasdaq: GLYC) announced today that Harout Semerjian, ...

GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

1mon ago, source: Nasdaq

ROCKVILLE, Md.--(BUSINESS WIRE)-- GlycoMimetics, Inc. (the “Company”) (NASDAQ:GLYC) today announced that the Compensation Committee of the Company’s Board of Directors approved the grant on ...

GlycoMimetics Inc

4d ago, source: U.S. News & World Report

Picking the best bond ETF can be hard with so many options available. Here's what the experts suggest focusing on.

GlycoMimetics Inc.

1mon ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

GlycoMimetics Inc.

15d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...